Mazindol for Cocaine Abuse - 2 - Tabular View

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Mazindol for Cocaine Abuse - 2

This study has been completed.

Study NCT00000277. Last updated on June 23, 2005. Information provided by National Institute on Drug Abuse (NIDA)

This Tabular View shows the required WHO registration data elements as marked by ^†

Descriptive Information Fields

Brief Title ^†

Mazindol for Cocaine Abuse - 2

Official Title ^†

Mazindol for Cocaine Abuse

Brief Summary

The purpose of this study is to evaluate high and low dose mazindol for cocaine abuse.

Detailed Description

Study Phase

Phase II

Study Type ^†

Interventional

Study Design ^†

Treatment

Primary Outcome Measure ^†

Side effects
Drug use
Retention

Secondary Outcome Measure ^†

Condition ^†

Cocaine-Related Disorders

Intervention ^†

Drug: Mazindol

MEDLINE PMIDs

Links

Recruitment Information Fields

Recruitment Status ^†

Completed

Enrollment ^†

Start Date ^†

Completion Date

Eligibility Criteria ^†

Please contact site for information.

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Contacts ^††

Location Countries ^†

United States

Administrative Information Fields

NCT ID ^†

NCT00000277

Organization ID

NIDA-09250-2

Secondary IDs ^††

P50-09250-2

Study Sponsor ^†

National Institute on Drug Abuse (NIDA)

Collaborators ^††

VA Connecticut Healthcare System

Investigators ^†

Principal Investigator:

Thomas R Kosten, M.D.

VA Connecticut Healthcare System

Information Provided By

National Institute on Drug Abuse (NIDA)

Verification Date

December 2002

First Received Date ^†

September 20, 1999

Last Updated Date

June 23, 2005

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.